Literature DB >> 25854903

Effects of dilatation types during percutaneous nephrolithotomy for less radiation exposure: a matched-pair pilot study.

Bünyamin Yildirim1, Mutlu Ates1, Mustafa Karalar1, Yigit Akin2, Ibrahim Keles1, Emre Tuzel3.   

Abstract

AIM: To evaluate exposure to radiation during percutaneous nephrolithotomy (PCNL) by comparing balloon-type renal dilatation (BTRD) and amplatz-type renal dilatation (ATRD).
MATERIALS AND METHODS: Retrospectively, 454 patients were documented and matched-pair analyses were performed. According to matched-paired criteria, in Group 1 (n = 78) BTRDs were used and in Group 2 (n = 78) ATRDs were used. Demographic, operative, and postoperative data including complications were recorded. Criteria for matched-pair analyses included age, gender, stone burden and localization, body mass index, presence of obstruction in intravenous urography, diabetes mellitus, previous extracorporeal shock wave lithotripsy and/or renal surgery even open and/or PCNL.
RESULTS: The mean follow-up was 11.9 ± 1.1 months, and mean age was 44.8 ± 13.7 years. Time to provide accessing into kidney, total time of exposure to X-ray, and time of exposure to X-ray until accessing into kidney were significantly lower in Group 1 than Group 2 (p < 0.003, 0.006, and 0.039, respectively).
CONCLUSIONS: BTRD may provide shorter exposure to radiation than ATRD for patients as well as operating room staff. Additionally, BTRD can provide rapid access into kidney than ATRD without significantly shorter operation time.

Entities:  

Keywords:  Nephrolithiasis; Operating room; Percutaneous nephrolithotomy; Radiation

Mesh:

Year:  2015        PMID: 25854903     DOI: 10.1007/s00508-015-0711-0

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  30 in total

1.  Percutaneous pyelolithotomy. A new extraction technique.

Authors:  I Fernström; B Johansson
Journal:  Scand J Urol Nephrol       Date:  1976

Review 2.  Complications in percutaneous nephrolithotomy.

Authors:  Maurice Stephan Michel; Lutz Trojan; Jens Jochen Rassweiler
Journal:  Eur Urol       Date:  2006-10-25       Impact factor: 20.096

3.  The percutaneous nephrolithotomy global study: classification of complications.

Authors:  Gaston Labate; Pranjal Modi; Anthony Timoney; Luigi Cormio; Xiaochun Zhang; Michael Louie; Magnus Grabe; Jean Rosette On Behalf Of The Croes Pcnl Study Group
Journal:  J Endourol       Date:  2011-07-13       Impact factor: 2.942

4.  Use of different types of dilator systems in the prevention of complications of percutaneous (PC) renal surgery.

Authors:  M A Heggagi; A Karsza; E Szüle
Journal:  Acta Chir Hung       Date:  1991

5.  Factors affecting blood loss during percutaneous nephrolithotomy using balloon dilation in a large contemporary series.

Authors:  Jeffrey J Tomaszewski; Marc C Smaldone; Tina Schuster; Stephen V Jackman; Timothy D Averch
Journal:  J Endourol       Date:  2010-02       Impact factor: 2.942

Review 6.  Advances in percutaneous nephrolithotomy.

Authors:  Jodi A Antonelli; Margaret S Pearle
Journal:  Urol Clin North Am       Date:  2012-10-24       Impact factor: 2.241

7.  Factors affecting bleeding during percutaneous nephrolithotomy: single surgeon experience.

Authors:  Tolga Akman; Murat Binbay; Erhan Sari; Emrah Yuruk; Abdulkadir Tepeler; Muzaffer Akcay; Ahmet Yaser Muslumanoglu; Ahmet Tefekli
Journal:  J Endourol       Date:  2011-01-08       Impact factor: 2.942

8.  Tubeless percutaneous nephrolithotomy: is it really less morbid?

Authors:  Iqbal Singh; Arvind Singh; Gyanendra Mittal
Journal:  J Endourol       Date:  2008-03       Impact factor: 2.942

9.  Tubeless and stentless percutaneous nephrolithotomy in patients requiring supracostal access.

Authors:  Murat Gonen; Tufan Cicek; Hakan Ozkardes
Journal:  Urol Int       Date:  2009-06-08       Impact factor: 2.089

10.  Third prize: contemporary percutaneous nephrolithotripsy: 1585 procedures in 1338 consecutive patients.

Authors:  Mordechai Duvdevani; Hassan Razvi; Mario Sofer; Darren T Beiko; Linda Nott; Ben H Chew; John D Denstedt
Journal:  J Endourol       Date:  2007-08       Impact factor: 2.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.